Literature DB >> 7923566

Phase I study of escalating does of carboplatin.

R Mick, M J Ratain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7923566     DOI： 10.1007/bf00685667

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  3 in total

1.  GM-CSF, carboplatin, doxorubicin: a phase I study.

Authors:  E A Poplin; D S Alberts; J J Rinehart; H O Smith; J A Neidhart; E M Hersh
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

Review 2.  Statistical approaches to pharmacodynamic modeling: motivations, methods, and misperceptions.

Authors:  R Mick; M J Ratain
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.

Authors:  M J Egorin; D A Van Echo; S J Tipping; E A Olman; M Y Whitacre; B W Thompson; J Aisner
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.